Hedgehog Pathway Inhibitor Improves IPF
Hedgehog pathway signaling inhibitor ENV-101 blocks signals that can lead to lung fibrosis and scarring and may lead to remodeling of early fibrosis.
Stay updated with breaking news from Tobym Maher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hedgehog pathway signaling inhibitor ENV-101 blocks signals that can lead to lung fibrosis and scarring and may lead to remodeling of early fibrosis.
WASHINGTON — In patients with idiopathic pulmonary fibrosis, yearly lung function decline rates did not improve with two different dosages of ziritaxestat, according to an American Thoracic Society International Conference presentation.“Unfortunately, ziritaxestat did not improve clinical outcomes compared with placebo in patients with IPF receiving standard of care,” Toby M.
These 2 randomized clinical trials compare the efficacy and safety of 2 doses of the autotaxin inhibitor ziritaxestat vs placebo in patients with idiopathic pul